$CCRD
CoreCard Corp Stock $ccrd

$ccrd Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000143774922010975 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$24.28M	$8.912M
YoY Change	172.49%	12.91%
Cost Of Revenue	$7.456M	$4.429M
YoY Change	68.34%	26.33%
Gross Profit	$16.83M	$4.483M
YoY Change	275.37%	2.19%
Gross Profit Margin	69.3%	50.3%
Selling, General & Admin	$1.751M	$917.0K
YoY Change	90.95%	-15.87%
% of Gross Profit	10.41%	20.46%
Research & Development	$3.324M	$2.101M
YoY Change	58.21%	128.87%
% of Gross Profit	19.75%	46.87%
Depreciation & Amortization	$1.328M	$855.0K
YoY Change	55.32%	185.0%
% of Gross Profit	7.89%	19.07%
Operating Expenses	$5.075M	$3.018M
YoY Change	68.16%	50.3%
Operating Profit	$11.75M	$1.465M
YoY Change	702.25%	-38.42%
Interest Expense	-$103.0K
YoY Change
% of Operating Profit	-0.88%
Other Income/Expense, Net	$37.00K	$75.00K
YoY Change	-50.67%	-44.85%
Pretax Income	$11.69M	$1.407M
YoY Change	730.63%	-3.96%
Income Tax	$3.017M	$367.0K
% Of Pretax Income	25.82%	26.08%
Net Earnings	$8.670M	$1.040M
YoY Change	733.65%	-0.67%
Net Earnings / Revenue	35.7%	11.67%
Basic Earnings Per Share	$1.00	$0.12
Diluted Earnings Per Share	$1.00	$0.12
COMMON SHARES
Basic Shares Outstanding	8.656M	8.899M
Diluted Shares Outstanding	8.686M	8.933M

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.54M	$31.00M
YoY Change	-20.83%	1.51%
Cash & Equivalents	$24.54M	$31.00M
Short-Term Investments
Other Short-Term Assets	$3.270M	$1.059M
YoY Change	208.78%	8.17%
Inventory
Prepaid Expenses
Receivables	$18.26M	$5.069M
Other Receivables	$0.00	$220.0K
Total Short-Term Assets	$46.08M	$37.35M
YoY Change	23.37%	-5.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.46M	$7.555M
YoY Change	64.87%	212.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.807M	$1.788M
YoY Change	112.92%
Other Assets	$4.901M	$4.111M
YoY Change	19.22%	19.92%
Total Long-Term Assets	$23.61M	$16.48M
YoY Change	43.22%	54.06%
TOTAL ASSETS
Total Short-Term Assets	$46.08M	$37.35M
Total Long-Term Assets	$23.61M	$16.48M
Total Assets	$69.69M	$53.83M
YoY Change	29.45%	7.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.173M	$781.0K
YoY Change	434.31%	109.95%
Accrued Expenses	$638.0K	$262.0K
YoY Change	143.51%	-10.58%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.58M	$7.403M
YoY Change	110.5%	-21.34%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.325M	$2.965M
YoY Change	12.14%	31.78%
Total Long-Term Liabilities	$3.881M	$3.783M
YoY Change	2.59%	50.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.58M	$7.403M
Total Long-Term Liabilities	$3.881M	$3.783M
Total Liabilities	$19.46M	$11.19M
YoY Change	74.0%	-6.26%
SHAREHOLDERS EQUITY
Retained Earnings	$47.71M	$31.05M
YoY Change	53.69%	35.62%
Common Stock	$16.36M	$16.09M
YoY Change	1.69%	3.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$13.66M	$4.351M
YoY Change	213.93%
Treasury Stock Shares	$382.4K	$114.5K
Shareholders Equity	$50.22M	$42.65M
YoY Change
Total Liabilities & Shareholders Equity	$69.69M	$53.83M
YoY Change	29.45%	7.02%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$8.670M	$1.040M
YoY Change	733.65%	-0.67%
Depreciation, Depletion And Amortization	$1.328M	$855.0K
YoY Change	55.32%	185.0%
Cash From Operating Activities	$313.0K	-$2.326M
YoY Change	-113.46%	-140.86%
INVESTING ACTIVITIES
Capital Expenditures	$2.737M	$1.496M
YoY Change	82.95%	177.55%
Acquisitions
YoY Change
Other Investing Activities	$55.00K	-$532.0K
YoY Change	-110.34%	-46.8%
Cash From Investing Activities	-$2.682M	-$2.028M
YoY Change	32.25%	31.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.332M	$2.712M
YoY Change	-14.01%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.332M	-$2.605M
YoY Change	-10.48%
NET CHANGE
Cash From Operating Activities	$313.0K	-$2.326M
Cash From Investing Activities	-$2.682M	-$2.028M
Cash From Financing Activities	-$2.332M	-$2.605M
Net Change In Cash	-$4.700M	-$6.955M
YoY Change	-32.42%	-268.69%
FREE CASH FLOW
Cash From Operating Activities	$313.0K	-$2.326M
Capital Expenditures	$2.737M	$1.496M
Free Cash Flow	-$2.424M	-$3.822M
YoY Change	-36.58%	-174.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9001311
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9001311
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8618951
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8689815
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	382360
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	311496
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	3.50
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	3.50
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1341000	USD
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8618951
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24544000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29244000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18264000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5547000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3270000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2046000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	46078000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	36837000	USD
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	6252000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	6355000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12456000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10371000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4901000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4585000	USD
CY2022Q1	us-gaap	Assets Assets	69687000	USD
CY2021Q4	us-gaap	Assets Assets	58148000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4173000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2763000	USD
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1031000	USD
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2263000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3370000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2145000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	638000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	404000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4004000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1004000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2367000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	43874000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69687000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58148000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24284000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8912000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	7456000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	4429000	USD
CY2022Q1	us-gaap	Marketing Expense MarketingExpense	66000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2274000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15583000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10853000	USD
CY2021Q1	us-gaap	Marketing Expense MarketingExpense	37000	USD
CY2022Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	316000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1685000	USD
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	164000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	880000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	556000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3324000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	549000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2101000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3009000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2708000	USD
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3881000	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3421000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	11753000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1465000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	90000	USD
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-103000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	90000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	16271000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	16261000	USD
CY2021Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-133000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	37000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	75000	USD
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	13659000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11687000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	11327000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1407000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	1040000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	39044000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	50223000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-193000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-194000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	47714000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3017000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	367000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8670000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1040000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.00
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.00
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8655529
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8899011
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8685698
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8933090
CY2022Q1	us-gaap	Profit Loss ProfitLoss	8670000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8671000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1044000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	44151000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2712000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	107000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1040000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	57000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	42647000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	43874000	USD
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2332000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8670000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2028000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	50223000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8670000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1040000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1328000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	855000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	57000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-58000	USD
CY2021Q1	ccrd	Noncash Interest Income NoncashInterestIncome	37000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-103000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-133000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12717000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1799000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	1159000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-204000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	129000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	33000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	832000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	67000	USD
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1225000	USD
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-358000	USD
CY2022Q1	ccrd	Increase Decrease In Deferred Revenue Current IncreaseDecreaseInDeferredRevenueCurrent	-1232000	USD
CY2021Q1	ccrd	Increase Decrease In Deferred Revenue Current IncreaseDecreaseInDeferredRevenueCurrent	-528000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	234000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	211000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3054000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2239000	USD
CY2022Q1	ccrd	Increase Decrease In Deferred Revenue Noncurrent IncreaseDecreaseInDeferredRevenueNoncurrent	152000	USD
CY2021Q1	ccrd	Increase Decrease In Deferred Revenue Noncurrent IncreaseDecreaseInDeferredRevenueNoncurrent	101000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	313000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2326000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2737000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1496000	USD
CY2021Q1	ccrd	Payments For Notes And Interest Receivable PaymentsForNotesAndInterestReceivable	550000	USD
CY2022Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	55000	USD
CY2021Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	18000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2682000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	107000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2332000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2712000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2332000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2605000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4700000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6955000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	29244000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37956000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24544000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	31001000	USD
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	2306000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24284000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8912000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24284000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8912000	USD
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	39.11
CY2022Q1	ccrd	Ownership Percentage OwnershipPercentage	0.28	pure
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	3807000	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-103000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-133000	USD
CY2022Q1	ccrd	Number Of Stockbased Compensation Plans In Effect NumberOfStockbasedCompensationPlansInEffect	3	pure
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	57000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	USD
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	39.11
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	59000
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.35
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	686560	USD
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	59000
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P6Y4M24D
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	17.35
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	686560	USD
CY2022Q1	ccrd	Operating Lease Rightofuse Asset And Lease Liability OperatingLeaseRightofuseAssetAndLeaseLiability	4273000	USD
CY2021Q4	ccrd	Operating Lease Rightofuse Asset And Lease Liability OperatingLeaseRightofuseAssetAndLeaseLiability	3955000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041	pure
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	317000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	284000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1044000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1339000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1009000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	629000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	513000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	68000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4602000	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	317000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	284000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2022Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	USD

Files In Submission

Name	View Source	Status
0001437749-22-010975-index-headers.html	Edgar Link	pending
0001437749-22-010975-index.html	Edgar Link	pending
0001437749-22-010975.txt	Edgar Link	pending
0001437749-22-010975-xbrl.zip	Edgar Link	pending
ccrd-20220331.xsd	Edgar Link	pending
ccrd-20220331_cal.xml	Edgar Link	unprocessable
ccrd-20220331_def.xml	Edgar Link	unprocessable
ccrd-20220331_lab.xml	Edgar Link	unprocessable
ccrd-20220331_pre.xml	Edgar Link	unprocessable
ex_368054.htm	Edgar Link	pending
ex_368055.htm	Edgar Link	pending
ex_368056.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
ins20220331_10q.htm	Edgar Link	pending
ins20220331_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CCRD
CoreCard Corp Stock $ccrd

2022 Q1 Form 10-Q Financial Statement

#000143774922010975 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCRD CoreCard Corp Stock $ccrd

2022 Q1 Form 10-Q Financial Statement

#000143774922010975 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCRD
CoreCard Corp Stock $ccrd